Bleeding Tendency 2025 PDF
Document Details
Uploaded by FabulousIridium6393
Ain Shams University
2025
Prof. Mohamed Moostafa
Tags
Summary
This document covers the physiology of normal hemostasis, and the causes and diagnosis of bleeding disorders in children. It details learning objectives, normal hemostasis phases, and various bleeding disorders and their investigation.
Full Transcript
Bleeding tendency Prof. Mohamed Moostafa LEARNING OBJECTIVES 1- To Know and understand the physiology of normal hemostasis 2- To Enumerate the causes of bleeding disorders in children 3- To have a systematized approach...
Bleeding tendency Prof. Mohamed Moostafa LEARNING OBJECTIVES 1- To Know and understand the physiology of normal hemostasis 2- To Enumerate the causes of bleeding disorders in children 3- To have a systematized approach for diagnosing child with bleeding 4- To Identify common bleeding disorders based on clinical and laboratory characteristics and know lines of managements NORMAL HEMOSTASIS PHASES OF HEMOSTASIS: - vasoconstriction - Endothelial injury and formation of the platelet plug; through: A) Platelet adhesion is by binding of platelet surface receptor GPIb to von Willebrand factor (VWF) in the subendothelium B) Platelet aggregation through binding GPIIb/IIIa receptor on the platelet surface to fibrinogen This mechanism is tested in vitro by platelet count, platelet function tests and VWF assay 1 N.B. Bleeding time is historically used for a long time as a diagnostic tool, but it is subjective, lacking sensitivity and specificity - Formation of fibrin clot by the coagulation cascade: a) The intrinsic pathway involves activation of factor IXa which in presence of VIIIa activates factor X. Tested in vitro by activated partial thromboplastin clotting time [aPTT]). b) The extrinsic pathway involves activation of VII (factor VIIa) which in presence of tissue factor activates factor X. tested in vitro by in vitro by prothrombin time [PT]). c) Common pathway: Both pathways converge on the activation of factor X which that converts prothrombin to thrombin. Thrombin converts fibrinogen from a soluble plasma protein into an insoluble fibrin clot (tested in the in vitro thrombin time [TT]). Eventually activated 13 convert unstable fibrin clot to stable clot - Removal of the clot by fibrinolysis. 2 3 DIFFERENTIAL DIAGNOSIS OF BLEEDING DISORDERS Vascular lesions: Usually produce palpable purpura - Hereditary: hereditary hemorrhagic telangiectasia (AD) - Acquired: a) Meningococcemia: life threatening emergency condition 4 b) IgA vasculitis (Henoch-Schönlein purpura) c) Other systemic CT diseases e.g., HHT, scurvy, corticosteroids, SLE, Platelet defects: Thrombocytopenia: Definition – Thrombocytopenia is defined as a platelet count